Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

In both human patients and murine models, the progression from insulitis to diabetes is neither immediate nor inevitable, as illustrated by the innocuous versus destructive infiltrates of BDC2.5 transgenic mice on the nonobese diabetic (NOD) versus C57BL/6.H-2g7 genetic backgrounds. Natural killer (NK)-cell-specific transcripts and the proportion of NK cells were increased in leukocytes from the aggressive BDC2.5/B6.H-2g7 lesions. NK cell participation was also enhanced in the aggressive lesions provoked by CTLA-4 blockade in BDC2.5/NOD mice. In this context, depletion of NK cells significantly inhibited diabetes development. NOD and B6.H-2g7 mice exhibit extensive variation in NK receptor expression, reminiscent of analogous human molecules. NK cells can be important players in type 1 diabetes, a role that was previously underappreciated.

[1]  M. Mattéi,et al.  Genetic control of diabetes progression. , 1997, Immunity.

[2]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[3]  G. Eisenbarth,et al.  Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. , 2003, Diabetes.

[4]  T. Hanafusa,et al.  Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. , 1985, Clinical and experimental immunology.

[5]  D. Greiner,et al.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.

[6]  P. Avner,et al.  Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. , 2001, Genomics.

[7]  P. Parham,et al.  Variable receptors controlling activation and inhibition of NK cells. , 2002, Current opinion in immunology.

[8]  G. Eisenbarth,et al.  Late Progression to Diabetes and Evidence for Chronic β-Cell Autoimmunity in Identical Twins of Patients With Type I Diabetes , 1995, Diabetes.

[9]  J. Bluestone,et al.  Impairment of NK cell function by NKG2D modulation in NOD mice. , 2003, Immunity.

[10]  G. Morahan,et al.  A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice. , 2003, Diabetes.

[11]  L. Chatenoud,et al.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Lafferty,et al.  T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.

[13]  M. Smyth,et al.  The Role of NK Cells in Autoimmune Disease , 2002, Autoimmunity.

[14]  A. F. Campese,et al.  Expression of Activated Notch3 in Transgenic Mice Enhances Generation of T Regulatory Cells and Protects against Experimental Autoimmune Diabetes1 , 2003, The Journal of Immunology.

[15]  P. Morel,et al.  Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function 1 , 2003, The Journal of Immunology.

[16]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[17]  Troy Krahl,et al.  Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry , 1998, Nature Medicine.

[18]  P. Santamaria,et al.  Ly-49P Activates NK-Mediated Lysis by Recognizing H-2Dd 1 , 2000, The Journal of Immunology.

[19]  K. Watanabe,et al.  Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice. , 1991, Diabetes research.

[20]  T. Saruta,et al.  The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice. , 1991, Diabetes research (Edinburgh, Scotland).

[21]  L. Teyton,et al.  Testing the NKT cell hypothesis of human IDDM pathogenesis. , 2002, The Journal of clinical investigation.

[22]  B. Samten,et al.  NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen 1 , 2004, The Journal of Immunology.

[23]  C. Benoist,et al.  Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.

[24]  J. Novak,et al.  NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. , 2002, Immunity.

[25]  J. Satoh,et al.  Immunologic Aspects of the Nonobese Diabetic (NOD) Mouse: Abnormalities of Cellular Immunity , 1983, Diabetes.

[26]  J. Markmann,et al.  Prevention of Recurrent Autoimmune Diabetes in BB Rats by Anti-Asialo-GM1 Antibody , 1988, Diabetes.

[27]  L. Kaer,et al.  The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice , 2001, Nature Medicine.

[28]  L. Chatenoud,et al.  CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. , 1997, Journal of immunology.

[29]  D. Raulet,et al.  Expression and function of NK cell receptors in CD8+ T cells. , 2001, Current opinion in immunology.

[30]  A. Rabinovitch,et al.  Natural killer cell depletion and diabetes mellitus in the BB/Wor rat (revisited) , 1993, Diabetologia.

[31]  S. Seki,et al.  Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by α-Galactosylceramide in Mice , 2001, The Journal of Immunology.

[32]  H. Garchon,et al.  Protection Against Diabetes and Improved NK/NKT Cell Performance in NOD.NK1.1 Mice Congenic at the NK Complex1 , 2001, The Journal of Immunology.

[33]  W. Seaman,et al.  Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. , 1987, Journal of immunology.

[34]  C. Benoist,et al.  Cellular and molecular changes accompanying the progression from insulitis to diabetes , 1999, European journal of immunology.

[35]  M. Smyth,et al.  Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. , 2001, International immunology.

[36]  H. Hall,et al.  Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. , 2004, International immunology.

[37]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[38]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.